Literature DB >> 2415286

Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain.

M B Max, C E Inturrisi, R F Kaiko, P Y Grabinski, C H Li, K M Foley.   

Abstract

We studied the cerebrospinal fluid (CSF) and plasma concentration-time profiles of morphine, methadone, and beta-endorphin after lumbar epidural or intrathecal injection in 17 patients with cancer. After epidural injection, all three drugs reached peak levels in lumbar CSF within 34 minutes that were 50 to 1300 times higher than free drug concentrations in plasma. The rate of decline of CSF levels correlated with drug lipid solubility (methadone [t1/2 = 73 minutes] greater than morphine [126 minutes] greater than beta-endorphin [317 minutes]). Plasma levels were comparable with those after intragluteal injection of the same dose. In four patients given intrathecal morphine or methadone, CSF at the C1-2 level contained high levels of morphine as early as 1 hour after injection, but levels of methadone were lower or undetectable. Three of 17 patients reported improved analgesia initially, but none were improved at 2 weeks after chronic therapy. We conclude that analgesia induced by intrathecal or epidural morphine injections is caused by drug acting at both spinal and supraspinal sites. The use of spinal opiates such as morphine is of limited value in patients whose pain is not adequately managed by high systemic doses of morphine-like drugs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415286     DOI: 10.1038/clpt.1985.237

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

1.  An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception.

Authors:  M C Ko; N N Naughton
Journal:  Anesthesiology       Date:  2000-03       Impact factor: 7.892

2.  Plasma morphine-3-glucuronide, morphine-6-glucuronide and morphine concentrations in patients receiving long-term epidural morphine.

Authors:  J J Schneider; P J Ravenscroft; J D Cavenagh; A M Brown; J P Bradley
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

3.  Side effects during continuous epidural infusion of morphine and fentanyl.

Authors:  M J White; E J Berghausen; S W Dumont; K Tsueda; J A Schroeder; R L Vogel; M F Heine; K C Huang
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

4.  [Not Available].

Authors:  J Jage
Journal:  Schmerz       Date:  1989-09       Impact factor: 1.107

5.  [The estimation of the i.m. morphine-equivalent in cancer pain treatment with different opioids or different routes of administrations. Practical meaning and limitations.].

Authors:  J Jage; R K Portenoy; K M Foley
Journal:  Schmerz       Date:  1990-06       Impact factor: 1.107

Review 6.  Opioid analgesics: comparative features and prescribing guidelines.

Authors:  N I Cherny
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

Review 7.  Side effects of intrathecal and epidural opioids.

Authors:  M A Chaney
Journal:  Can J Anaesth       Date:  1995-10       Impact factor: 5.063

8.  [Drug therapy for tumor pain I. Properties of non-opioids and opioids.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1994-12       Impact factor: 1.107

9.  [Pharmacotherapy of cancer pain : 2. Use of opioids.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-01       Impact factor: 1.107

10.  Itch and analgesia resulting from intrathecal application of morphine: contrasting effects on different populations of trigeminothalamic tract neurons.

Authors:  Hannah R Moser; Glenn J Giesler
Journal:  J Neurosci       Date:  2013-04-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.